Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
LENZ Therapeutics’ Merger with Graphite Bio
Idorsia’s Reacquisition of Global Rights to Aprocitentan
Wilson Sonsini Goodrich & Rosati represented Idorsia in the transaction. Idorsia Ltd (SIX:IDIA) announced that it entered into an agreement with Janssen Biotech Inc., one of...
Alto Neuroscience’s $35 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Alto Neuroscience on the deal. Alto Neuroscience announced the closing of a $35 million Series B financing led by Lightswitch...
Equillium’s Acquisition of Metacrine
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...